cigna glp-1 drops employee coverage of obesity drugs Cigna checks medical cost growth

[DOI] [PubMed] [Google Scholar] 27.Davies M., Faerch L., Jeppesen O.K., Pakseresht A., Pedersen S.D., Perreault L., Rosenstock J., Shimomura I., Viljoen A., Wadden T.A., et al

The comparison worth paying attention to is retatrutide vs tirzepatide both are Eli Lilly compounds, and tirzepatide only received approval in 2023

These mechanisms complement GLP-1 effects through different neural and hormonal pathways, creating a more comprehensive appetite suppression signal than GLP-1 alone

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults-2024 Update

liraglutide, n = 38)

Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice